GALT: Galectin Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 208.62
Enterprise Value ($M) 256.92
Book Value ($M) -60.24
Book Value / Share -0.97
Price / Book -3.46
NCAV ($M) -60.73
NCAV / Share -0.98
Price / NCAV -3.44

Profitability (mra)
Return on Invested Capital (ROIC) -3.55
Return on Assets (ROA) -2.03
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.77
Current Ratio 1.77

Balance Sheet (mrq) ($M)
Current Assets 27.71
Assets 28.20
Liabilities 88.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -38.07
Net Income -41.07
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -32.97
Cash from Investing 0.00
Cash from Financing 40.03

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 29,390 150,545 19.52
2024-05-02 52,296 246,820 21.19
2024-05-01 29,987 107,319 27.94
2024-04-30 35,116 48,295 72.71
2024-04-29 58,987 66,054 89.30

(click for more detail)

Similar Companies
FLGC – Flora Growth Corp. FTLF – FitLife Brands, Inc.
FWBI – First Wave BioPharma, Inc. GDTC – CytoMed Therapeutics Limited
GHSI – Guardion Health Sciences, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Galectin Therapeutics